Clinical Trials Browser

Phase 2 × Etanercept × Myeloid × Clear all

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00005853 2010-04-02

Biological Therapy in Treating Patients With Myelodysplastic Syndrome

Phase 2 Completed

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes

Clinical Trials

Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes

Biological Therapy in Treating Patients With Myelodysplastic Syndrome